Condition (MeSH)
Neurogenic Bowel
ClinicalTrials.gov lists 33 trials for Neurogenic Bowel or a narrower condition beneath it. James J. Peters Veterans Affairs Medical Center has the most among industry and government lead sponsors, with 6.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
33 of the 33 trials are tagged with Neurogenic Bowel itself; the rest are tagged with a narrower condition beneath it.
When did Neurogenic Bowel trials start? (13)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 3 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 5 |
| 2021 | 4 |
| 2020 | 3 |
| 2019 | 1 |
| 2018 | 3 |
| 2016 | 3 |
Showing 10 of 13 earlier years.
No forecast is made for this condition: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 8 trials still running at the 2026-10-09 snapshot; registered median of 29 months across 17 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Neurogenic Bowel trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 5 |
| Phase 3 | 2 |
| Phase 4 | 1 |
| Not applicable | 22 |
| Observational | 3 |
How many Neurogenic Bowel trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Completed | 15 |
| Terminated | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Neurogenic Bowel trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| James J. Peters Veterans Affairs Medical Center | 6 |
| Wellspect HealthCare | 2 |
| Coloplast A/S | 1 |
| Dentsply International | 1 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Combination of Neostigmine and Glycopyrrolate | 3 |
| Neostigmine and Glycopyrrolate | 2 |
| Effectiveness - NS and USP Glycerin - Second Intervention | 1 |
| Intravenous Neostigmine and Glycopyrrolate | 1 |
| Transdermal Neostigmine and Glycopyrrolate | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Neurogenic Bowel? (23)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The effect of neuromuscular electrical stimulation on bowel management in people with chronic spinal cord injury-An IDEAL 2a pilot study. | Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland | 2025 | Yes |
| Multisite Transcutaneous Spinal Stimulation for Walking and Autonomic Recovery in Motor-Incomplete Tetraplegia: A Single-Subject Design. | Physical therapy | 2022 | Yes |
| Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease. | Spinal cord | 2022 | Yes |
| The Neurogenic Bowel Dysfunction score (NBD) is not suitable for patients with multiple sclerosis. | Spinal cord | 2022 | Yes |
| Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers. | Topics in spinal cord injury rehabilitation | 2021 | Yes |
Showing 5 of 23 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.